Targeted drugs for liver cancer help patients prolong their lives.
At present, for patients with more than three liver tumors or larger liver tumors, doctors often consider local embolization, but because of the great side effects, they sometimes consider using targeted drugs to help patients prolong their lives and improve their quality of life.
Ou, director of the Department of Hematology and Oncology of Fuxin Hospital, said that targeted drugs mainly target the special structure of cancer cells, and will not cause excessive damage to normal tissues during the attack, and patients will not feel excessive discomfort. In recent ten years, with the development of targeted drugs, patients' discomfort has been greatly reduced, their life span has been gradually extended and their quality of life has been greatly improved.
Diet and life are also important to prevent liver cancer.
People want to prevent liver cancer, and doctors think that besides controlling hepatitis B and C, they should pay more attention to diet and life.
Wu Mingshun, director of the Department of Gastroenterology, Taipei Wan Fang Hospital, pointed out that if a person suffers from hepatitis B and hepatitis C, it is easy to get liver cancer, which is also related to his eating habits. For example, grains that are easy to deliquesce often contain aflatoxin, which will aggravate the occurrence of cancer. Or like unclean diet and overwork, it will also aggravate the formation of cancer.
Actively cooperate with treatment, and the quality of life is better.
Doctors also remind patients with liver cancer not to believe folk remedies casually. If you can communicate well with doctors and actively cooperate with treatment, you will have a chance to shrink the tumor and have a better quality of life.
There are 6 tumors in the liver, and Ma Yong has 8 years of anti-cancer history.
Join us and pay attention to your health every day! Line @ ID: @ Subscribe to Healthy Aloha Audio-visual Channel to read health knowledge more easily: /beauty/article/33740 Keywords: tumor, liver cancer, Europe, target drug, hepatitis B.